Literature DB >> 8277819

Nitric oxide: a signal for ADP-ribosylation of proteins.

B Brüne1, S Dimmeler, L Molina y Vedia, E G Lapetina.   

Abstract

Nitric oxide (NO), a highly reactive gas, is now established as a major messenger molecule regulating blood vessel dilation, immune functions and serving as a neurotransmitter in brain and peripheral nervous system. NO can also act as a tumoricidal and bactericidal molecule. The effect of NO to dilate blood vessels is largely explained by stimulation of soluble guanylate cyclase (a heme-iron containing protein) leading to formation of cGMP and protein phosphorylation. This is considered to be the main physiological signaling mechanism of NO. NO also binds to non-heme iron-containing proteins and this has been considered as a pathophysiological or cytotoxic action of NO. Furthermore, NO, more correctly nitrosonium (NO+) which can be formed by the removal of one electron, reacts with protein SH-groups to cause the S-nitrosylation of proteins. We have recently established a link between NO and the S-nitrosylation and mono-ADP-ribosylation of the enzyme glyceraldehyde 3-monophosphate dehydrogenase, which adds a further protein modification mechanism for NO action. This links the formation of the second messenger molecule NO to post-translational protein modification and adds a new dimension to NO in the communication of intracellular signals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8277819     DOI: 10.1016/0024-3205(94)00775-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

1.  Induction of inducible heme oxygenase (HO-1) in the central nervous system: is HO-1 helpful or harmful?

Authors:  Y Matsuoka; M Okazaki; Y Kitamura
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

2.  Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes.

Authors:  P V Sulakhe; L Sandirasegarane; J P Davis; X T Vo; W J Costain; R R Mainra
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

3.  The synthesis of ATP by glycolytic enzymes in the postsynaptic density and the effect of endogenously generated nitric oxide.

Authors:  K Wu; C Aoki; A Elste; A A Rogalski-Wilk; P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target.

Authors:  M Cao; A Westerhausen-Larson; C Niyibizi; K Kavalkovich; H I Georgescu; C F Rizzo; P A Hebda; M Stefanovic-Racic; C H Evans
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

5.  Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery.

Authors:  F Lovren; C Triggle
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Nitric oxide depresses GABAA receptor function via coactivation of cGMP-dependent kinase and phosphodiesterase.

Authors:  E M Wexler; P K Stanton; S Nawy
Journal:  J Neurosci       Date:  1998-04-01       Impact factor: 6.167

7.  Niacin metabolism and Parkinson's disease.

Authors:  Tetsuhito Fukushima
Journal:  Environ Health Prev Med       Date:  2005-01       Impact factor: 3.674

8.  Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.

Authors:  J P Maciejewski; C Selleri; T Sato; H J Cho; L K Keefer; C F Nathan; N S Young
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

9.  Complex transcriptional control of the streptokinase gene of Streptococcus equisimilis H46A.

Authors:  K Gase; T Ellinger; H Malke
Journal:  Mol Gen Genet       Date:  1995-06-25

Review 10.  Nitric oxide synthase: expression and expressional control of the three isoforms.

Authors:  U Förstermann; H Kleinert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.